Počet záznamov: 1
rosuvastatín kalcium
SYS d000068718 LBL 00000nz--a2200181n--4500 005 20250606221738.2 008 160101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a D02.065.884.650 065 $a D02.455.526.510.432.500 065 $a D02.886.590.700.650 065 $a D03.383.742.775 066 $a 01 $c 03 150 $a rosuvastatín kalcium $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a rosuvastatín, vápenatá soľ $2 slo 450 $w v $a rosuvastatín vo forme vápenatej soli $2 slo 450 $w v $a rosuvastatín $2 slo 450 $w v $a ZD 4522 $2 slo 550 $7 sllk_us_auth*d019821 $Y Simvastatin $w b $a simvastatín 550 $7 sllk_us_auth*d000924 $Y Anticholesteremic Agents $w P $a anticholesterolemiká 550 $7 sllk_us_auth*d019161 $Y Hydroxymethylglutaryl-CoA Reductase Inhibitors $w P $a inhibítory hydroxymetylglutaryl-CoA-reduktázy 550 $7 sllk_us_auth*d019821 $Y Simvastatin $w p $a simvastatín 665 $a 2016 (2001) $2 eng 680 9-
$i A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES. $2 eng 750 -2
$a Rosuvastatin Calcium $2 eng 980 $x M
Počet záznamov: 1